Rein Therapeutics, Inc. Shares Outstanding (Cover Page)
Rein Therapeutics, Inc. (RNTX) had Shares Outstanding (Cover Page) of 86.27 million shares as of 2026-08-12, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-12: Entity Common Stock, Shares Outstanding 86.27M shares.
- 2026-05-13: Entity Common Stock, Shares Outstanding 85.54M shares.
- 2026-03-24: Entity Common Stock, Shares Outstanding 28.04M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 26.29M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 86.27M shares 10-Q · filed 2026-08-14 |
| 2026-05-13 | 85.54M shares 10-Q · filed 2026-05-15 |
| 2026-03-24 | 28.04M shares 10-K · filed 2026-03-26 |
| 2025-11-10 | 26.29M shares 10-Q · filed 2025-11-14 |
| 2025-08-11 | 23.31M shares 10-Q · filed 2025-08-14 |
| 2025-05-14 | 22.15M shares 10-Q · filed 2025-05-15 |
| 2025-03-27 | 21.99M shares 10-K/A · filed 2025-04-30 |
| 2025-03-24 | 28.04M shares 10-K/A · filed 2026-04-27 |
| 2024-11-12 | 21.67M shares 10-Q · filed 2024-11-14 |
| 2024-08-12 | 21.67M shares 10-Q · filed 2024-08-14 |
| 2024-05-13 | 21.59M shares 10-Q · filed 2024-05-15 |
| 2024-04-25 | 16.87M shares 10-K/A · filed 2024-04-29 |
| 2024-04-12 | 16.97M shares 10-K · filed 2024-04-15 |
| 2023-10-11 | 4.54M shares 10-Q · filed 2023-10-13 |
| 2023-08-09 | 4.54M shares 10-Q · filed 2023-08-11 |
| 2023-05-04 | 4.54M shares 10-Q · filed 2023-05-08 |
| 2023-03-16 | 4.54M shares 10-K/A · filed 2023-04-28 |
| 2022-10-28 | 90.82M shares 10-Q · filed 2022-11-01 |
| 2022-08-11 | 90.82M shares 10-Q · filed 2022-08-15 |
| 2022-05-02 | 90.82M shares 10-Q · filed 2022-05-05 |
| 2022-03-25 | 90.57M shares 10-K · filed 2022-03-28 |
| 2021-11-09 | 90.57M shares 10-Q · filed 2021-11-12 |
| 2021-08-09 | 90.55M shares 10-Q · filed 2021-08-11 |
| 2021-05-07 | 90.33M shares 10-Q · filed 2021-05-11 |
| 2021-03-19 | 90.21M shares 10-K · filed 2021-03-24 |
| 2020-11-11 | 40.68M shares 10-Q · filed 2020-11-12 |
| 2020-08-04 | 39.26M shares 10-Q · filed 2020-08-05 |
| 2020-05-08 | 29.09M shares 10-Q · filed 2020-05-11 |
| 2020-03-20 | 27.81M shares 10-K · filed 2020-03-30 |
| 2019-11-05 | 27.81M shares 10-Q · filed 2019-11-07 |
| 2019-08-05 | 27.81M shares 10-Q · filed 2019-08-06 |
| 2019-05-06 | 26.71M shares 10-Q · filed 2019-05-08 |
| 2019-03-26 | 14.88M shares 10-K · filed 2019-03-29 |
| 2018-11-01 | 14.75M shares 10-Q · filed 2018-11-07 |
| 2018-08-06 | 14.74M shares 10-Q · filed 2018-08-07 |
| 2018-05-09 | 14.74M shares 10-Q · filed 2018-05-09 |
| 2018-03-26 | 14.73M shares 10-K · filed 2018-04-02 |
| 2017-11-09 | 14.72M shares 10-Q · filed 2017-11-09 |
| 2017-08-10 | 14.71M shares 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |